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Abstract: The emergence of the new scientific field known as nanomedicine is being catalyzed by multiple improvements 
in nanoscience techniques and significant progress in materials science, especially as regards the testing of novel and so-
phisticated biomaterials. This conjuncture has furthered the development of promising instruments in terms of detection, 
bioanalysis, therapy, diagnostics and imaging. Some of the most innovative new biomaterials are protein-inspired 
biomimetic materials in which modern biotechnology and genetic-engineering techniques complement the huge amount of 
information afforded by natural protein evolution to create advanced and tailor-made multifunctional molecules. Amongst 
these protein-based biomaterials, Elastin-like Recombinamers (ELRs) have demonstrated their enormous potential in the 
fields of biomedicine and nanoscience in the last few years. This broad applicability derives from their unmatched proper-
ties, particularly their recombinant and tailor-made nature, the intrinsic characteristics derived from their elastin-based 
origin (mainly their mechanical properties and ability to self-assemble as a result of their stimuli-responsive behavior), 
their proven biocompatibility and biodegradability, as well as their versatility as regards incorporating advanced chemical 
or recombinant modifications into the original structure that open up an almost unlimited number of multifunctional pos-
sibilities in this developing field. This article provides an updated review of the recent challenges overcome by using these 
recombinant biomaterials in the fields of nano- and biomedicine, ranging from nanoscale applications in surface modifica-
tions and self-assembled nanostructures to drug delivery and regenerative medicine. 
Keywords: Elastin-like recombinamers, self-assembly, stimuli-responsive, tissue engineering, surface modification, drug de-
livery, nanotechnology. 
INTRODUCTION 
Protein based-materials have attracted the attention of 
numerous researchers in recent years as promising advanced 
biomaterials for use in the field of biomedicine, especially as 
a result of recent improvements in recombinant DNA tech-
nology, which allow us to design and manufacture materials 
by exploiting the abilities of natural proteins [1]. Some of the 
most widely studied protein-derived materials are the so-
called elastin like recombinamers (ELRs) [2-4], taking into 
account its recombinant nature this new nomenclature was 
proposed [5] in replacement of the more conventional termi-
nology elastin- like polymers (ELPs), which include those 
first chemically synthesized materials. 
Elastin is an elastic, insoluble protein that is present in 
many tissues such as skin or lung where elasticity is a key 
requirement. Elastin possesses several extraordinary charac-
teristics, such as an ability to undergo high deformation 
without breaking and subsequent recovery of the original 
conformation once the stress disappears. The origin of this 
ability resides in the structure of the recurrent sequences 
(VPGVG, VPGG, VGVAPG) found in the soluble elastin  
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precursor tropoelastin [6]. It is also worth noting that this 
elastic behavior is an energy-conserving process, thus allow-
ing the resulting elastic fibers to undergo billions of relaxa-
tion-stretching cycles [7]. 
ELRs are smart, genetically engineered biomaterials in-
spired by natural elastin and based on the very same recur-
ring amino acid sequences as found in tropoelastin. Some of 
the most relevant characteristics of ELRs, which are derived 
from those of the natural protein, serve as an example of how 
elastin’s mechanical properties are retained by way of cross-
linked ELR matrices [8]. These mechanical properties be-
come more interesting in conjunction with other properties 
such as biocompatibility, stimuli-responsive behavior and 
the ability to self-assemble [9-10]. The most widely studied 
ELRs are based on the recurring pentapeptide sequence Val-
Pro-Gly-Xaa-Gly, where Xaa is any natural amino acid ex-
cept proline. All functional ELRs present temperature sensi-
tiveness in aqueous solution. Thus, below a characteristic 
temperature, known as the transition temperature (Tt), the 
polymer chains remain disordered and relatively extended 
with a random coil conformation. They are also fully hy-
drated, mainly by a hydrophobic hydration characterized by 
the presence of ordered water clathrate-like structures around 
the apolar moieties in the polymer [11]. Once this Tt is ex-
ceeded, this disordered structure is “broken” and the “re-
leased” polymer chains adopt an ordered structure known as 
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a -spiral, which folds hydrophobically to generate a phase 
separation. The initial step in this process is the formation of 
triply stranded -spiral filaments, which go on to form 
nanoparticles several hundreds of nanometers in length as a 
result of continued growth of these filaments. Finally, the 
filaments come together to form a visibly phase-separated 
state. The process is completely reversible upon lowering the 
temperature below the Tt [10]. However, temperature is not 
the only stimuli to which ELRs are responsiveness: other 
external stimuli, such as pH [12], UV-vis light [13] or ion 
concentration [14] also have a marked effect on the behavior 
of ELRs.  
Some disagreement still standing about the -spiral sig-
nificance, some authors have demonstrated the existence of 
other conformations, such as polyproline II in elastin [15], 
proposing an alternative model where -spiral are accompa-
nied by isolated -turns [16] and extended structures. [15, 
17] The presence of high amount of water in the system, 
increasing the dynamics of the recombinamer chains would 
explain the apparent contradictory results obtained by differ-
ent experimental techniques. 
ELRs are obtained by recombinant DNA technologies, 
which allow an extremely precise control over the amino 
acid composition. This technology opens up the possibility 
of designing ELRs with the specific properties required for a 
certain application [18, 19]. This design versatility, together 
with their high biocompatibility, bioactivity and self-
assembling behavior, makes ELRs unmatchable materials for 
studies in the biomedical field [18]. As a result, ELRs have 
been used in wide variety of applications, such as tissue en-
gineering [20] or drug delivery [21]. Similarly, they have 
also been applied in the field of nanotechnology due to the 
range of nanostructures, such as nanofibers [22] or nanopar-
ticles [23], that can be formed from them.  
The aim of this review is to try to shed some light on the 
state-of-the-art of these and other applications of ELRs in the 
fields of biomedicine and nanotechnology. 
ELRs IN TISSUE ENGINEERING 
The potential of ELRs in biomedical engineering has 
been widely explored over the last decade, particularly in the 
field of tissue engineering for the construction of bioartificial 
tissues. Indeed, these recombinant protein polymers can even 
be suitably designed and molded to restore the structural and 
biological functions of the extracellular matrix (ECM) [24]. 
The ability to biosynthesize ELRs guarantees their repro-
ducibility, thereby avoiding the potential variability and risk 
of using animal-derived structural proteins. Moreover, their 
characteristics make them biomimetic and re-absorbable 
materials with a defined mechanical behavior [25, 26] that 
allows them to be cast with a specific topography [27, 28] 
whilst retaining their tunable temperature responsiveness 
[29] and controlled structural features. ELR sequences based 
on the repetition of certain modular ECM structural protein 
motifs allow the physicochemical [10], mechanical [30], and 
biological [31] properties of the natural proteins from which 
they are derived to be reproduced [32]. These properties 
have made ELRs one of the materials of choice when inves-
tigating new biomaterials for biomedical applications. 
It has been widely demonstrated that ELRs are able to be 
formed into plastic or viscoelastic scaffolds for tissue engi-
neering [33]. Due to the possibility of partially substituting 
their amino acid sequence to modulate potential cross-
linking or their ability to self-assemble, ELRs that are able to 
form physical or chemical gels have been synthesized. 
Moreover, some of them are injectable and can form a stable 
continuous implant in situ, a property that is particularly in 
demand as regards minimizing surgical invasiveness [28, 34, 
35]. Such injectable 3D ELR scaffolds have been shown to 
be suitable for supporting in vitro cell culture and the differ-
entiation of adipose-derived stem cells into chondrocytes 
without the need to add external supplements [36], and 
Chaikof’s group has confirmed their stealth properties when 
implanted in vivo, where they show long-term stability in 
different tissues without inducing an inflammatory response 
[37]. Although these ELR-based hydrogels confirmed their 
effectiveness as tissue-engineering scaffolds with excellent 
mechanical properties and biocompatibility, the absence of a 
cell-anchorage sequence limits both cell adhesion and subse-
quent colonization of the artificial scaffold, even if the im-
plant is retained in the host’s body for more than a year [37]. 
In a recent publication from the same group, this deficiency 
was overcome by both coating their surface with the struc-
tural ECM protein fibronectin or integrating this protein into 
the ELR gel by absorption or cross-linking, which resulted in 
modulated cell adhesion, viability, proliferation, and migra-
tion of both endothelial and mesenchymal stem cells [38]. 
It is well known that binding between cell-surface recep-
tors and ECM proteins activates the intracellular signaling 
pathways that deeply influence a cell’s behavior and fate 
[39]. This activation is mostly due to interaction between 
specific motifs on the ECM proteins and cell receptors. The 
short amino acid sequences that form protein motifs can eas-
ily be incorporated into the sequences of recombinant pro-
tein-based polymers (or recombinamer) using standard ge-
netic-engineering techniques, thus endowing these recombi-
namers with functionality, for example to increase cell-
transfection efficiency [40], promote angiogenesis [41], in-
hibit endothelial cell migration [42] or to nucleate bone min-
eralization [43]. Similarly, the inclusion of integrin-mediated 
cell-adhesion motifs (short sequences present in several 
structural ECM proteins) into some advanced scaffolds has 
been reported to be one of the factors that prevent contrac-
tion and scar formation in skin and nerve-tissue regeneration. 
In this respect, the well-known Arg-Gly-Asp (RGD) guides 
the colonization of these artificial ECMs by recruiting the 
host’s own cells, thereby avoiding cell-cell binding, limiting 
wound contraction and aiding tissue regeneration [44]. The 
inclusion of integrin-binding sites into the ELR backbone 
also favors material-cell interactions [45].  
Several examples of RGD-containing bio-functionalized 
ELRs have been reported to present higher rates of cell at-
tachment with respect to controls [46, 47]. This enrichment 
is preserved when the ELR-RGD is coated onto other bio-
logically inert substrates, or is cast in 3D cell supports [48, 
49]. Two recent studies in this field described the results 
obtained by coating scaffolds made of conventional biomate-
rials as poly(lactic) acid (PLA) or poly(lactide-co-glycolide) 
(PLGA) with ELR-RGD. In both cases, the ELR layer cover-
ing the primary component conferred a stronger cell-
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adhesion ability. In the first work [50], the authors described 
an alternative and more efficient bio-functionalization of 
model PLA surfaces achieved using ELR-RGD instead of 
conventional short peptides containing an RGD motif. PLA 
scaffolds were either absorbed or covalently grafted with 
protein material in the form of peptides, ELRs or bovine 
serum albumin (BSA) and their bio-functionalization effi-
ciency evaluated. All possible combinations were compared 
in early and late cell-surface interaction studies and three 
different factors found to influence the process. The first of 
these is the presence of RGD, which always significant im-
proved early cell adhesion and cell proliferation, and the 
second is the type of molecule presenting the RGD motif, 
with ELR-RGD being a significant enhancer with respect to 
the short peptides-RGD. The final factor is the covalent liga-
tion of molecules to PLA. This resulted in larger cell areas 
on the ELR-grafted surfaces, cells which acquired a well 
spread morphology with strong stress fibers, possibly due to 
better transmission of the mechanical stimuli. The resulting 
hybrid ELR-PLA scaffolds restricted nonspecific protein 
adsorption, enhanced cell adhesion and anchorages, and in-
creased the proliferation ratio, thus demonstrating that the 
use of ELRs is a more efficient strategy for guiding cellular 
activity than the use of short peptides [50].  
In the second example, scaffolds for neural tissue engi-
neering were produced by coating microporous PLGA with 
various concentrations of ELR-RGD via a simple tempera-
ture-dependent sol-gel transition. Subsequent in vitro assays 
showed that the ELRs improved neural progenitor cell adhe-
sion and proliferation in a concentration-dependent manner. 
Moreover, when the cell culture on ELR-RGD is grown in 
combination with retinoic acid, differentiation of the pro-
genitor cells into neuronal and astroglial lineages is induced 
[51]. 
The use of ELRs ensures complete composition control 
and allows the influence of different parameters to be studied 
as independent components. In this regard, a preliminary 
study of the influence of cell ligand density and scaffold ri-
gidity on neurite growth has been carried out to improve the 
performance of a 3D hydrogel formed for neural tissue re-
generation. Hydrogel stiffness was modulated by using in-
creasing cross-linker/ELR stoichiometric ratios, whereas the 
cell adhesion motif density was controlled by homogenously 
mixing RGD and its scrambled non-adhesive negative con-
trol. The resulting data confirmed that the softer and RGD-
richer 3D hydrogel is the best scaffold for stimulating neurite 
growth [52].  
A similar ELR-RGD scaffold has been used recently to 
cultivate pancreatic beta-TC6 cells in which the formation of 
islet-like structures was observed. In this study, the surfaces 
were easily coated by making use of one of the most charac-
teristic ELR properties, namely the temperature-dependent 
phase transition that determines the sol-gel transition. In con-
trast to conventional substrates, the beta cells seeded on the 
ELR-RGD surfaces showed high cell viability, self-
organisation into multicellular spheroids with an islet-like 
architecture, and clustering, presumably caused by the pres-
ence of RGD, which triggers a signaling cascade, in the ELR 
backbone. Moreover, the pancreatic cells grown on ELR-
RGD improved insulin expression and secretion stimulated 
by glucose, increased the expression of cell-to-cell adhesion 
molecules and of ECM fibrous proteins. The overall results 
suggested that ELR-RGD promotes pseudoislet formation 
and therefore that it is a suitable scaffold for manufacturing 
pancreatic islet cells for transplantation in vitro. [53]  
The possibility of employing ELR-RGD materials to im-
prove the regeneration, or induce the differentiation, of endo-
thelium [41], cartilage [36], bone [48, 54], muscle [55], pan-
creas [53], or neuronal tissue [51] has been described. Inter-
esting results have also been obtained in the case of epithe-
lial oral tissue, for which conventional artificial 3D scaffolds 
are unable to sustain the potential proliferative capacity of 
oral epithelial cells during extended culture times. In order to 
improve cell adhesion on the natural structural protein colla-
gen, an ELR-RGD/collagen mixture was electrospun and 
cross-linked to fabricate a suitable highly porous epithelial 
3D scaffold [56]. The nanofiber 3D ELR scaffold is initially 
cultivated with human fibroblasts that are able to proliferate, 
infiltrate the network and neo-synthesize their own ECM, 
finally forming a lamina propria equivalent. Co-culture with 
oral epithelial cells seeded over this lamina equivalent gen-
erates a non-keratinized, multilayered oral epithelial mucosal 
equivalent. The 3D hybrid scaffold is able to sustain in vitro 
culture for six weeks. Moreover, it was found to express the 
specific oral epithelial marker and is histologically very 
similar to the native version. In contrast, the collagen-only 
electrospun 3D scaffold used as negative control was poorly 
colonized by the cells and its resulting epithelium was thin-
ner [57]. Other types of epithelial cells have also been found 
to benefit if cultured on ELR-RGD as a substrate for subse-
quent subretinal transplantation. Indeed, ELR-RGD supports 
are able to sustain the growth and maintain the phenotype, 
and functional characteristics of retinal pigment epithelial 
cells [58, 59]. 
RGD is not the only cell adhesion motif engineered into 
an ELR back-bone. Thus, Tirrell and coworkers have com-
pared the in vitro cell-adhesion properties of bidimensional 
ELR scaffolds containing the human fibronectin motifs RGD 
or Arg-Glu-Asp-Val (REDV) [47, 60, 61]. Although both 
these motifs were found to enhance the adhesion of HUVEC 
endothelial cells, the former was more efficient than the lat-
ter, which, in contrast, specifically interacts with the endo-
thelium [62, 63]. 
The porosity of the artificial scaffold has been reported to 
be one of the parameters that induce regeneration for pore 
diameters ranging from 40 to 140 μm [64]. As well as in 
regenerative medicine, another important property of a tem-
porary scaffold is that it must degrade and be absorbed once 
the host can neo-synthesize its own ECM. In light of this, a 
number of trigger-biodegradable biomaterials have been bio-
synthesized [65, 66]. Both these features can be achieved in 
3D scaffolds obtained by chemical cross-linking of an enzy-
matically biodegradable ELR-REDV. Thus, HUVECs cul-
tured in highly interconnected porous 3D hydrogels are able 
to infiltrate the porous network and acquire a well spread 
morphology [67]. The same ELR-REDV and collagen have 
also been enzymatically cross-linked using variable ratios of 
both proteins to form 3D scaffolds. The resulting collagen-
ELR scaffolds improved the elasticity and bioactivity in 
terms of adhesion selectivity and proteolytic sensitivity with 
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respect to those formed from collagen alone. A comparison 
of HUVEC and fibroblast cultures grown on the hybrid scaf-
folds confirmed that REDV specificity (in terms of both 
morphology and proliferation rate) was ratio-dependent. This 
study therefore suggests that the collagen-ELR ratio can be 
varied to fit the characteristics of different tissues, thereby 
preventing hypertrophy of the scar and modulating angio-
genesis [63].  
A further bioactive sequence identified in a secreted 
heparin-binding protein (CCN1) that is expressed at injury-
repair sites was recently incorporated into a triblock copoly-
mer to enhance cell adhesion. This 20-mer peptide, namely 
V2, specifically binds to integrin v3, membrane receptors 
present in HUVECs. As a result, the HUVECs cultured on 
the ELR-V2 adhered, spread, migrated and also showed a 
quiescent phenotype in the presence of an integrin-mediated 
stimulus [68].  
A series of tailored-made ELRs have been synthesized in 
order to obtain adult cardiomyocytes. In this case, due to 
their poor proliferation, instead of inserting a cell-adhesion 
motif into the ELR sequence, the authors preferred to include 
the receptor-binding domain of insulin-like growth factor 
binding protein 4 (IGFBP4), which promotes the differentia-
tion of embryonic stem cells into cardiomyocytes. The ELR-
IGFBP4 sol-gel transition allowed stable coating of the cul-
ture substrate and the possibility of cell differentiation was 
subsequently evaluated. A high IGFBP4 concentration is 
required to induce this differentiation in a standard culture as 
it is very unstable. A comparison of the results obtained in 
this study showed that absorbed ELR-IGFBP4 is more effi-
cient than absorbed IGFBP4 alone or the standard method of 
cardiomyocyte differentiation involving continuous addition 
of soluble IGFBP4 to the medium. As such, the functional-
ized ELR-IGFBP4 improves IGFBP4 stability, thereby re-
sulting in a stronger and constant effect on the culture [69]. 
The studies highlighted above indicate that the use of 
ELRs to construct 2/3D scaffolds or to improve the bioactiv-
ity of conventional materials has significantly increased the 
performance of conventional scaffolds. Moreover, their 
modular nature means that the function of biomaterials can 
be enhanced by redesigning their amino acid composition 
and adding bioactive motifs that may convert the scaffold 
from being a mere support to a vector that performs the fine 
and delicate role of cell-material communicator during re-
constitution of the new host tissue. 
APPLICATION OF ELRs IN SURFACE ENGINEER-
ING 
Surface engineering is an area in the field of biomaterial 
science devoted to the control and modification of surfaces 
and interfaces in order to study the molecular mechanisms 
underlying protein adsorption and cell-extracellular interac-
tions. A large number of biological reactions occur either on 
surfaces or at interfaces, and cell behavior can be condi-
tioned by a given well-defined topography and bioactivity of 
these surfaces. Moreover, in the field of implantable devices, 
surface contacts with the organism dictate cellular behavior 
and biointegration. In light of the above, the development of 
appropriate systems that mimic in vivo cellular environments 
in order to enable in vitro studies of cell-matrix interactions 
is a key requirement for future progress in several areas of 
bioscience and biotechnology. [70] 
The ability to manufacture surface coatings that are bio-
compatible and stable under physiological conditions is a 
valuable objective in surface engineering in order to design 
devices with an improved biological performance. In this 
sense, ELRs are excellent candidates for the development of 
smart surfaces as, together with their extensive potential to 
self-assemble, their sequence, functionality and bioactivity 
can be closely controlled using recombinant technologies. 
Modification of Surface Topography by ELRs 
The design of systems with a well-defined topography 
and controlled chemical and mechanical properties is a hot 
research topic due to their potential biomedical applications, 
especially for improving cell-material interactions [71, 72]. 
Modification with stimuli-responsive ELRs allows surfaces 
to vary their physical and chemical properties in response to 
external stimuli, which is often essential for endowing ad-
vanced materials and devices with desirable features. 
In this sense, Bandiera [73] has described the behavior of 
different cell lines cultured on surfaces coated with an ELR 
that adopts a defined pattern of concentric circles. The good 
adhesiveness displayed by all the cell lines studied is note-
worthy, with the specific behavior depending on the cell type 
concerned. The difference in cell response appears to reside 
in the ability of cells to somehow discriminate the physical 
structure of the substrate. Thus, human endothelial and 
epithelial cell lines align along the grooves, probably in the 
direction in which they encounter the least resistance, as al-
ready described for other biological systems. [74] 
To study the influence of different topographies on cell 
behavior, Garcia-Arevalo et al. carried out a comparative 
analysis of the precise contribution and importance of two 
different surface topographies, namely nanofibers and films, 
on cell behavior [45]. Inert surfaces were covered with a film 
or an electrospun layer of an aqueous solution of ELRs bear-
ing a specific adhesion sequence such as RGD. Surfaces with 
different topographies showed different properties in terms 
of wettability, roughness and surface free-energy. The mor-
phological and proliferative responses of the seeded human 
fibroblasts were analyzed, and the authors concluded that 
higher proliferation rates were obtained for those surfaces 
coated with films which presented a higher surface energy 
and were more hydrophilic. The lower proliferative values 
for surfaces covered with fibers was due to the greater ad-
sorption of non-specific proteins from the culture medium, 
thereby hindering cell-surface interactions. The surface ad-
hesion and proliferative values for both these topographies 
were higher for those surfaces coated with the RGD-
containing ELR than for the control surfaces covered with an 
ELR lacking the RGD domain [45]. 
Similarly, Martin et al. have fabricated 3D structures 
made of ELR-based hydrogels by means of replica molding. 
These structures have a fully controlled surface micro-
topography in addition to tunable mechanical properties and 
a smart nature. These surfaces exhibited grooves or pillars 
with different dimensions and distances. The controlled to-
pography and bioactivity resulting from the RGD domain are 
noteworthy factors to study and, eventually, to regulate cell 
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behavior [27]. The hydrogels were obtained by chemical 
cross-linking on top of PDMS stamps; their swelling and 
mechanical properties could be modulated by varying the 
polymer:cross-linker ratio. The thermoresponsive behavior 
of the starting ELRs was maintained in the hydrogel, which 
exhibited different dimensions above and below its transition 
temperature, without topography modification [27]. Mi-
cropatterned gels were subsequently obtained from elastin-
like amphiphilic multiblock copolymers with reversible 
thermogelling properties under mild, physiological condi-
tions. In this case, the one-step physical gelation process 
comprises heating the ELR solution above its gelation tem-
perature on top of a PDMS mould (see Fig. 1). The mechani-
cal properties of the hydrogel can be tuned by varying the 
polymer solution concentration [28]. Micropatterned mem-
branes have been obtained from ELRs containing an RGD 
domain that incorporate both biomolecular and physical sig-
naling by Tejeda-Montes et al. [75] These membranes are 
obtained by using hexamethylene diisocyanate (HDMI) as 
chemical cross-linker. Rat mesenchymal stem cells (rMSCs) 
attach to membranes both with and without RGD but only 
exhibit well-developed focal adhesion mediated by integrin 
binding for those containing an RGD domain. In membranes 
with surface topographies, cells show morphological varia-
tions and contact guidance depending on the surface topog-
raphy, exhibiting an aligned and thin morphology on chan-
nels and growing within and around the posts, with actin 
cytoskeletons engulfing them. This response of the cells to 
the membrane’s biomolecular and physical features suggests 
that both elements could be tailored to synergistically alter 
specific cell behavior. These microstructured substrates 
simulate the microscale structure of tissues and could be 
used as implantable platforms or as a substrate for studying 
spatially controlled cell behavior. 
In order to study the influence of surface chemistry and 
topography on bone marrow mesenchymal stem cell prolif-
eration and differentiation, micropatterned PIPAAm films 
were prepared and modified by adsorption of an elastin-like 
polymer containing an adhesion domain (ELR-RGD). Tak-
ing advantage of the thermal responsiveness of the ELR-
RGD, rhythmic temperature changes were applied to flex 
and contract the 2D scaffold in an attempt to mimic me-
chanical stress on the cells and to provide dynamic culture 
conditions that are expected to improve bone formation. The 
presence of the recombinamer proved crucial for maintaining 
cell attachment under dynamic culture conditions, as cor-
roborated using control tissue culture polystyrene surfaces 
(TCPS), for which the number of attached cells decreased 
with time under the same conditions [48].  
Biofunctionality Control Using ELRs 
Many physicochemical methodologies have been pro-
posed to modify the chemical and topographical features of 
substrates. Initial research mainly focused on the adsorption 
of natural proteins and short peptides. However, the use of 
engineered proteins can provide the advantages of both 
strategies and avoid the main drawbacks concerning the im-
munogenic problems presented by some proteins or the loss 
of effectiveness of oversimplified peptides. [20] In this 
 
Fig. (1). Micropatterned gels with different features obtained by ELR replica molding. Adapted with permission from Soft Matter [28]. 
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sense, Srokowski and Woodhouse have studied the physical 
adsorption of a family of ELRs that differ in terms of mo-
lecular weight and sequence length onto a Mylar surface as a 
way of understanding how surface properties can influence 
their bioactivity, especially their hemocompatibility. This 
study showed that the amount of adsorbed ELR increased 
with ELR sequence length and that surface coverage and 
stability improved, whereas hydrophilic adhesion forces 
and/or wettability decreased, with ELR sequence length. In 
other words, the longest polypeptides formed films with 
greater structural flexibility and associated water content. 
The dynamic nature of the adsorbed layer may be an impor-
tant factor that contributes to its biological response [76]. 
Additionally, a decrease in fibrinogen accretion and platelet 
adhesion was observed for ELR-coated compared to un-
coated surfaces, with the longest ELR coatings exhibiting 
lower levels of fibrinogen adsorption and platelet adhesion 
and therefore being the best thromboresistant coatings [77]. 
Janorkar et al. have studied the surface modification of 
TCPS plates by adsorption of differently modified ELRs and 
have demonstrated the influence of the physicochemical na-
ture of the substrate on cell activity. Thus, ELRs chemically 
conjugated with polyacrylic acid (ELR-PAA) and with poly-
ethyleneimine (ELR-PEI) were adsorbed onto TCPS plates, 
thereby leading to oppositely charged surfaces. Primary he-
patocytes were cultured on these surfaces and opposite ef-
fects on cell morphology and differentiated functions were 
found for them. For example, hepatocytes were found to 
spread on ELR-PAA coated surfaces but low liver-specific 
function was detected, whereas hepatocytes formed sphe-
roids on positively charged ELR-PEI surfaces and exhibited 
enhanced function for up to 21 days, as deduced from levels 
of urea and albumin production, with both ELR and PEI be-
ing required for this morphological control and functional 
enhancement [78].  
Surfaces based on natural polymers such as chitosan have 
also been modified to increase their bioactive character. In 
this sense, Barbosa et al. adsorbed different bioactive ELRs 
onto a chitosan hydrogel surface by simple deposition of the 
ELR dissolved in a water-based solution. Those chitosan 
hydrogels coated with ELRs containing an osteoconductive 
sequence promoted the deposition of hydroxyapatite (HAP) 
onto the surface [79]. Smart thin coatings obtained using 
ELRs containing the RGD cell-attachment sequence en-
hanced osteoblast adhesion and proliferation in comparison 
with the original chitosan substrate. An intermediate behav-
ior was found in the chitosan coated with an ELR lacking the 
RGD sequence. [80] These films have great potential as 
biomimetic biomaterial coatings. 
An ELR bearing the RGD adhesion motif has also been 
used recently to biofunctionalize an implantable material, 
namely a PLA model surface, in order to induce the regen-
eration of damaged tissue. In this application, hydrophobic-
ity and lack of bioactive properties appear to be drawbacks 
for rapid and effective biointegration. To overcome this 
handicap, PLA-based biomaterials were chemically func-
tionalized in order to be able to graft engineered proteins 
onto them. The results suggest that ELR functionalization 
creates a non-fouling coating that is able to restrict non-
specific protein adsorption [50]. Thus, covalently functional-
ized ELR surfaces are able to elicit twice as much cell at-
tachment (from 25% to 50% of cell spreading area) with 
respect to samples with adsorbed ELRs. Strong attachment 
to the surface improves both cell spreading, which is related 
to transmission of the mechanical properties from the surface 
to the cell via covalent grafting, and molecular stability in 
terms of prolonged efficacy and reproducibility.  
Other efforts have been devoted to modifying materials 
other than polymers, such as metals, in order to improve 
their properties for use as implantable materials by taking 
advantage of the features of ELRs. Some metals are widely 
used to manufacture implants due to their mechanical and 
physical features, such as their corrosion resistance, which is 
a central aspect of their biocompatibility. Recently, titanium 
has been coated with ELRs in order to improve its bioactiv-
ity and biocompatibility. Thus, Gonzalez et al. have func-
tionalized -type Ti alloys with ELRs by chemical surface 
modification in order to make implants for use in bone tissue 
engineering. The covalent immobilization of a recombinamer 
bearing the bioactive RGD motif onto Ti surfaces adequately 
functionalized by activation with oxygen plasma treatment 
induced higher cell recruitment and spreading of the os-
teoblast cells than for control surfaces. Consequently, these 
results demonstrate the great potential of ELR-coated Ti al-
loys for use as implantable materials, especially when taking 
into account that they also exhibit mechanical features simi-
lar to those of human cortical bone [81].  
The Layer-by-Layer Approach to Surface Coating 
A further physicochemical methodology proposed re-
cently for modifying the properties of different surfaces is 
known as the layer-by-layer approach (LbL). The sequential 
LbL adsorption of polyelectrolytes is a simple and versatile 
technique for the assembly of multilayer coatings [82]. The 
principle behind LbL adsorption lies in the existence of mul-
tiple intermolecular interactions, such as electrostatic con-
tacts, hydrophobic interactions and hydrogen bonding, in 
which the cooperative effects of multipoint attractions play 
the most important role. Ultrathin coatings based upon ELR 
conjugates offer tremendous potential for enhancing the bio-
compatibility of substrata, thereby generating bioactive and 
biomimetic surfaces that are able to modulate cell-substrate 
interactions [83].  
As an example, Golonka et al. have used the LbL meth-
odology to electrostatically self-assemble charged polymers 
consisting of ionic elastin-like recombinamers (ELRs), thus 
leading to thermoresponsive multilayer thin films on quartz 
or silicon. The ELR-containing lysine units served as a poly-
cation and the ELR with glutamic acid served as a polyan-
ion, both of which carry evenly distributed and equidistant 
charged moieties at pH 7. The multilayer film was found to 
be temperature-responsive under physiological conditions 
and to be resistant to salt solutions, with this robustness be-
ing an important factor for subsequent application as a bio-
compatible nanocoating [84]. ELRs chemically modified to 
carry different charges have been used by Swierczewska et 
al. for LbL electrostatic self-assembly. The charged poly-
mers consisted of elastin-like recombinamers coupled to 
polyethyleneimine (ELR-PEI), and therefore positively 
charged, and to polyacrylic acid (ELR-PAA) opposite; nega-
tively charged. When deposited on glass substrates, these 
ultrathin ELR-based multilayer nanoscale coatings promote 
Recent Contributions of Elastin-Like Recombinamers Current Topics in Medicinal Chemistry, 2014, Vol. 14, No. 7    7 
cell adhesion and proliferation in comparison with uncoated 
surfaces despite the polymer structure lacking a cell-
adhesion domain. Cell proliferation and cytoskeletal organi-
zation can be enhanced by increasing the number of bilayers, 
thus indicating that both the thickness and mechanical integ-
rity of the ELR multilayer play an important role in modulat-
ing the cellular response [85]. 
The LbL build-up of self-assembled multilayer films 
based on electrostatic and hydrophobic interactions, with 
alternating layers of chitosan and an ELR containing an os-
teoconductive sequence (HAP), was reported by Barbosa et 
al. [83] Modified surfaces with this ELR-HAP as the outer-
most layer maintained the temperature-responsive behavior 
of the starting ELR, thus combining the facile and versatile 
fabrication of multilayers with the concept of smart surfaces. 
In the same way, another smart thin biomimetic coating has 
been successfully fabricated using the same chitosan and 
another ELR containing an RGD adhesion sequence. This 
robust nanostructured multilayer coating was designed to 
have smart properties, with an acute and independent re-
sponse towards temperature, pH and ionic strength. In vitro 
studies showed enhanced SaOs-2 osteoblast-like cell adhe-
sion and activity for ELR-RGD coatings in comparison with 
those substrates for which the outermost layer was chitosan 
or scrambled RDG biopolymer coatings [83].  
The LbL technique can also be used to coat surfaces with 
complex geometries and shapes and can be extrapolated to 
three-dimensional structures. Thus, recent studies in this 
field have been devoted to the construction of microcapsules 
by the sequential adsorption of chitosan and a biomimetic 
elastin-like recombinamer containing an RGD sequence into 
nanostructured layers on inorganic microcapsule templates. 
Biocompatible microcapsules are especially interesting due 
to their potential role as carriers of biomolecules. These mi-
crocapsules were made starting from CaCO3 particles in the 
presence of BSA, which were coated with a different number 
of ELR-chitosan bilayers. After construction, the core was 
chelated with EDTA to form hollow microcapsules. These 
microcapsules were able to modify their size and permeabil-
ity due to the thermoresponsive nature of ELRs and, in addi-
tion, were found to be non-cytotoxic towards mouse fibro-
blast cells. The presence of different bioactive motifs in the 
ELRs conferred biological activity on them, thus making 
them a promising alternative for drug delivery and tissue 
engineering [86]. 
We can conclude that the LbL methodology produces ro-
bust coatings in substrates with different geometries. These 
examples also demonstrate that complex molecules like 
ELRs can be exploited as polyelectrolytes, and the resulting 
substrates could be useful for biomedical applications due to 
their thermoresponsive properties, biocompatibility and sta-
bility under physiological conditions. 
Smart Surfaces by ELR Grafting 
Stimuli-responsive polymers often retain their “smart” 
behavior, which can be harnessed for sensing applications, 
when grafted onto surfaces. Covalent attachment is often 
preferred to weaker interactions for this purpose due to in-
herent resistance to environmental degradation [87]. ELRs 
tethered to a surface via covalent bonding in the form of 
polymer brushes can also be used as stimuli-responsive sur-
faces because they are able to vary their physical and chemi-
cal properties in response to external stimuli. Generally 
speaking, stimuli-responsive surfaces are able to change their 
hydrophobicity due to conformational changes that occur 
around the transition temperature of the attached polymer. 
Thus, at temperatures below the transition temperature the 
surface is more hydrophilic because the polymer is in an 
expanded soluble conformation surrounded by hydrophobic 
hydration, whereas at temperatures above the transition tem-
perature the polymer is in a collapsed insoluble conformation 
that results in a more hydrophobic surface. The most com-
mon biomacromolecules that can be manipulated by stimuli 
include N-alkyl substituted polyacrylamide (i.e. PIPAAm), 
polyalcohols and natural or genetically engineered polypep-
tides, such as ELRs. Such changes in surface hydrophobicity 
in response to changes in temperature have been exploited in 
the field of chromatography by using matrices with grafted 
PIPAAm to separate substances that interact differently with 
the matrix, with biomolecules such as proteins adsorbing 
more strongly onto hydrophobic surfaces [88-90]. Similarly, 
chemical valves with controlled porosity can be made by 
grafting smart polymers to porous systems as the polymer 
transition affects the total free volume of the pores available 
for the solvent [91]. 
Controllable bacterial attachment and detachment has 
been achieved by using smart thermoresponsive surfaces 
together with ELR biofunctionalized bacteria. The surfaces 
were microcontact printed with a cell-repellent polymer and 
the uncoated specific areas biofunctionalized with an ELR 
covalently grafted to the surface. Five different types of 
ELR-bacteria conjugates were used for binding to ELR-
functionalized glass via hydrophobic interactions between 
the ELR molecules. Reversible bacterial attachment and de-
tachment was achieved by controlling the thermoresponsive 
phase transition of the ELRs. This arrangement solves the 
problem of bacterial cell death and contamination from cell 
division that occurs in microfluidic applications [92]. 
The hydrophobic surface changes make them very attrac-
tive for biological applications because most proteins and 
cells preferentially adsorb to hydrophobic surfaces, thus 
meaning that cell adsorption and desorption can be triggered 
[90]. This cell attachment and detachment is controlled by 
external stimuli such as temperature, pH and/or ionic 
strength and makes these surfaces attractive for use in mi-
crodevices for cell-based therapies. Cell-harvesting systems 
and technologies are powerful elements for the development 
of cell production, especially as regards their subsequent use 
in human therapies. Indeed, tissue engineering and regenera-
tive medicine will not easily become universally applicable 
without a reliable source of cells for therapeutic purposes 
[93]. 
In this sense, Okano et al. have developed a new tech-
nology for cell sheet detachment in an attempt to avoid the 
physical or proteolytic treatments that result in degradation 
of cell-surface proteins, which are vital for the cell-to-cell 
and cell-to-ECM interactions necessary for maintaining tis-
sue structure. Thus, in this approach, cells are cultured on 
temperature-responsive dishes created by grafting PNI-
PAAm onto ordinary tissue culture dishes (TCPS). The dish 
surface is relatively hydrophobic, and therefore suitable for 
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cell culture, under physiological conditions. A small tem-
perature reduction causes the surface to become very hydro-
philic, thereby releasing confluent sheets of culture cells. 
These cell sheets, with their deposited ECM, can then be 
transplanted into the host tissues. This system requires an 
adequate control of the thickness of the grafted PIPAAm, 
which is a critical issue for obtaining temperature-switchable 
attachment/detachment of the cultured cells. [94, 95] Follow-
ing a similar methodology, Kobatake et al. have developed a 
system for cell sheet engineering using ELR-coated smart 
surfaces. Thus, recombinamers carrying an RGD adhesion 
domain are adsorbed onto a hydrophobic dish. Once conflu-
ent, the cells seeded onto the coated plate can be detached 
from the dish as a sheet by lowering the temperature to 20 
ºC. This change in temperature reverses the co-aggregation 
and modifies the hydrophobicity of the plate surface, thus 
allowing cell sheets to be harvested. However, this system 
only allows cell-sheet detachment together with the previ-
ously adsorbed ELRs rather than cell harvesting, thus mak-
ing it non-reusable. [96] 
In contrast to the above procedure, Pierna et al. have re-
cently developed a new, reusable and efficient system for 
cell and cell-sheet harvesting based on smart surfaces with 
ELRs with a known molecular design grafted to them via 
their lysine-rich end as polymer brushes. Thermoresponsive 
surfaces have been obtained by covalent coupling of tailored 
ELRs via a “click” chemistry methodology.  
The biofunctionalized surfaces switch between cell ad-
herent and non-adherent states with a change in temperature 
due to the thermoresponsive properties of ELRs. As the ELR 
carries RGD domains in its structure, these adhesion do-
mains can be exposed or hidden by varying the temperature 
and can thus be used for cell harvesting. Cell analysis with 
human fibroblasts shows a high-grade of adhesion to the 
adherent state of the surface (37ºC) in which the ELR-RGD 
is in an aggregated form and presents the more polar adhe-
sion domain to the water interface, thus allowing “active” 
cell adhesion, viability and proliferation. A slight decrease in 
temperature triggers a reorganization of the recombinamer, 
thus resulting in exposure of the non-adherent domains and 
hiding of the RGD adhesion domains and detachment of the 
cell. This process allows single cells or cell sheets from lines 
such as fibroblasts and stem cells to be harvested in a quick 
and clean manner (Fig. 2). This new methodology avoids the 
drawbacks of previous cell-harvesting technologies as re-
gards close control of the thickness for grafted polymers 
(PIPAAm) [94] or the inability to reuse them. In this new 
system [96], an ELR monolayer is end-grafted to the surface 
in a covalent manner, thus allowing absolute control of the 
layer thickness. Moreover, the system can be reused over 
several cell-harvesting cycles due to the thermoresponsive 
behavior of brush-like grafted ELRs. In short, multiblock 
ELR design opens the way to the development of much more 
sophisticated systems that cannot be achieved using other 
alternatives. [97]  
To summarise, as discussed in the previous chapter, sur-
faces covered with different ELRs can promote cell adhe-
sion, spreading and proliferation, especially when the re-
combinamers carry a cell-adhesion domain. Additionally, 
films, multilayers or chemical grafts of these different coat-
ings allow surfaces with different topographies, and there-
fore different chemical and physical properties that can be 
tuned to modulate cell-substrate interactions, to be obtained. 
These findings represent a clear improvement as regards 
surface engineering with respect to the systems used previ-
ously. 
 
 
Fig. (2). Cell adhesion and detachment in a cell-harvesting sys-
tem for fibroblast and ADSC cell lines. Phase-contrast images of 
the same surface location after incubation at 37ºC and subsequent 
low-temperature treatment. Adapted with permission from Biomac-
romolecules [97].  
 
ELRS FOR DRUG DELIVERY  
The main objective of drug delivery is to get the required 
amount of active substance to the right place at the appropri-
ate time. Controlled-release systems are commonly used to 
prolong the time that the therapeutic dose is present effec-
tively in the body using a single dose, and to eliminate or 
minimize concentrations above that required therapeutically. 
In such systems, the bioactive agent is incorporated into a 
support that is generally formed by one or more kinds of 
materials, usually of a polymeric nature [98]. This section 
focuses on ELR-based polymeric materials and their role in 
controlled drug release. 
Drug Delivery from ELR-Based Hydrogels 
Hydrogels are three dimensional networks of polymers, 
peptides or polypeptides with characteristically high water 
content. This high degree of hydration, together with their 
porous morphology, is essential for the diffusion of hydro-
philic drugs, which is key for their use as vehicles for drug 
delivery [99]. Relative to hydrophobic drugs, amphiphilic 
polymeric materials provide both hydrophilic and hydropho-
bic environments and therefore usually result in enhanced 
drug solubility [100]. 
The first elastin-based polymers designed for drug re-
lease were simple devices in which a hydrogel of a chemi-
cally synthesized poly(VPGVG) was loaded with a water-
soluble drug, which was subsequently released by diffusion 
[101]. Since this simple system, other more complex systems 
have been created [102]. Moreover, the development of ge-
netic-engineering techniques has resulted in the creation of a 
wide range of elastin-based polymers with designs adapted 
to their final application. The transition temperature, type 
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and number of cross-linking sites and the molecular weight 
of the ELR are all genetically encodable properties [12, 29]. 
Thanks to our ability to vary the transition temperature, the 
vast majority of the ELR-based hydrogels developed for 
drug-delivery purposes have been created as injectable forms 
[29]. Injectable hydrogels display several important thera-
peutic advantages. For example, their implantation is charac-
terized by a minimally invasive technique, thereby minimiz-
ing the tissue damage and pain associated with conventional 
surgical procedures. Additionally, this technique allows ac-
cess to areas of the body that are otherwise difficult to reach 
and, with respect to the utilization of such hydrogels in the 
field of pharmacology, undesirable side effects associated 
with systemic drug delivery are reduced due to the specific 
and precise location. An injectable hydrogel must exhibit 
high fluidity at the time of injection and then undergoes a 
pronounced increase in its subsequent mechanical properties, 
thus resulting in the formation of a solid implant [103]. Ap-
propriately designed ELRs fulfill both these requirements as 
they display a liquid-like state below the transition tempera-
ture, thus allowing injection and making their mixture with 
drugs efficient and extremely simple [104], and they can 
form a depot either by exploiting the hydrophobic interac-
tions that take place above their Tt or by chemical bonds due 
to a previous specific modification of the ELR. For example, 
regarding the design of ELR-based hydrogels cross-linked 
by covalent bonds, Chilkoti's group has synthesized a battery 
of ELRs that differ from each other in the frequency of cys-
teine and the degree of hydrophobicity. These polymers are 
able to form disulfide cross-linked hydrogels in a matter of 
minutes under mildly oxidising conditions [105] and only 
non-toxic reagents are required during hydrogel formation. 
In another interesting approach, the high degree of transglu-
taminase specificity has been exploited to create a covalent 
cross-linked injectable hydrogel for cartilaginous applica-
tions [106]. Despite this, such examples remain an exception 
in the field of covalently cross-linked hydrogels as the prepa-
ration of most such gels requires extreme conditions, such as 
exposure to organic solvents, heat or high polymer concen-
trations [106-108], thus limiting their in vivo application.  
In order to avoid the toxicity associated with most forms 
of chemical cross-linking, especially for gels designed to be 
formed in situ, various strategies for the formation of physi-
cal hydrogels have been developed. Thus, a second approach 
exploits their ITT behavior, which is characteristic of these 
polymers, as a means of achieving the formation of physical 
cross-links. To this end, ELRs are designed as amphiphilic 
multi-block co-polymers with alternating hydrophilic and 
hydrophobic blocks in such a way that hydrophobic aggrega-
tion occurs below 37 °C in an aqueous solvent. This means 
that when the polymer is injected, it senses the body tem-
perature and the hydrophobic blocks interact physically with 
each other, thus giving rise to the cross-linking [109-111]. 
As an example, Sallach et al. have prepared a triblock co-
recombinamer in which a hydrophilic block (Tt > 37ºC) is 
flanked by two hydrophobic end blocks (Tt = 18ºC). This 
amphiphilic protein shows a minimal inflammatory response 
and robust stability for periods exceeding one year [34, 37]. 
In another interesting example, an ELR with a subphysi-
ological Tt of 28ºC conjugated to a radionuclide was been 
shown to form a local depot upon in vivo intratumoral injec-
tion; a subsequent reduction in tumor growth was detected 
[110].  
One of the main drawbacks of physical ELR-based hy-
drogels is the relatively weak nature of the physical interac-
tion mediated by the hydrophobic domains of the elastomeric 
motifs. Several new alternatives have been explored to over-
come this problem. Thus, a further step in the design of 
multiblock ELRs for the formation of physical hydrogels 
involves using cross-linking domains from peptide motifs 
other than elastin [99]. For example, silk fibroin domains, 
the primary sequence of which follows patterns such as 
GAGAGS, GAGAGY and GAGAGVGY, have been incor-
porated into the peptide backbone of the ELR, thus giving 
rise to so-called SELPs (silk elastin-like polymers) [112]. 
SELP-based hydrogels display better mechanical properties 
than their ELR-based counterparts due to the stability and 
irreversibility provided by the presence of the silk motifs, 
which adopt a characteristic anti-parallel -sheet secondary 
structure [113]. SELP hydrogels have been found to exhibit 
in vivo biocompatibility since no clinical signs of toxicity 
were observed up to one month after intradermal or subcuta-
neous injection [114]. As is the case with ELR-polymer solu-
tions, SELP ones can be mixed with drugs, thus allowing 
homogenous entrapment of the compound once the gelling 
process occurs. Thus, the release profiles for different com-
pounds, such as cytochrome c, theophylline, vitamin B12, 
the recombinant protein mitotoxin and several fluorescently 
labeled probes, have been explored and several parameters, 
such as the molecular weight of the drug, the concentration 
of the SELP and its specific composition, have been found to 
influence drug release [114, 115]. The application of SELPs 
has not been limited exclusively to drug carriers as their use 
for the localized matrix-mediated delivery of viral vectors 
has also been explored. For example, an SELP matrix em-
bedded with an adenovirus containing both thymidine 
kinase-1 and luciferase genes has been intratumorally in-
jected into a nude mouse model of head and neck tumor, thus 
resulting in a fivefold reduction in tumor volume with re-
spect to intra-tumoral injection of adenovirus in saline. 
Moreover, whereas expression in the animal injected with 
the SELP-based virus was confined to the tumor site, 50% of 
animals treated with the virus in saline showed liver dis-
semination [116]. In order to further assess the safety of this 
viral delivery system, a non-tumor bearing immunocompe-
tent mouse model was used. The ability of the mice to regain 
their normal weight and blood count was assessed, and it 
was shown that matrix-mediated gene delivery with the 
SELP offers a significant reduction in toxicity compared to 
the injection of free virus [117]. 
ELR Self-Assembly into Spherical Particles for Drug 
Delivery 
The ability of some ELRs to self-assemble to form nano- 
and micro-objects with spherical shapes has been used to 
achieve drug encapsulation. For example, microparticles has 
been obtained from both the chemical [118, 119] and recom-
binant [120] versions of poly(VPAVG), with the latter hav-
ing the subsequent advantage of forming a strictly monodis-
perse material. The presence of alanine in the third position 
gives the polymer a hysteresis behavior: polymer self-
assembly occurs above a Tt of 30ºC but the self-assembled 
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structures only solubilize again when a strong cooling of 12-
15 ºC is achieved [118]. This makes the polymer particles 
easy to use since, once formed, they are stable unless a 
strong undercooling occurs. Recombinant spherical particles 
have been used to entrap bone morphogenetic proteins 
(BMPs) with high efficiency, with sustained release over 14 
days in a bioactive way being observed. Moreover, no cyto-
toxicity was observed, thus corroborating the biocompatible 
character of these polymers [120].  
Numerous studies of the behavior of amphiphilic multi-
block ELRs have provided clear evidence for the tendency of 
such molecules to self-assembly into stable nano- and mi-
croparticles when the temperature is raised above the Tt of 
the polymer [121, 122]. For example, Chilkoti’s group has 
designed and synthesized a battery of ELRs that self-
assemble into micelles in the presence of a physiologically 
relevant trigger, such as a hyperthermic temperature in the 
range 3742ºC [123]. In a subsequent step, these ELR block 
copolymers were functionalized with the peptide ligand 
NGR (a vascular targeting agent). The micelles formed by 
this copolymer displayed higher cellular uptake than both the 
monomer form with the NGR and the micelle form without 
the NGR ligand. Additional examples of exploiting this 
thermosensitive behavior for application in cancer therapy by 
applying local hyperthermia will be discussed further in the 
next section since in such cases the ELR experiences a ther-
mal transition and also plays an active role in targeting the 
site of action.  
The inherent ability of amphiphilic ELRs to self-
assemble into spherical particles has also been exploited in 
the field of immunology. One of the most recent publications 
in this sense describes the production of a vaccine carrier in 
which an amphiphilic ELR is co-expressed with an antigenic 
peptide from a major membrane protein present in M. tuber-
culosis (Fig. 3) [124]. Above the Tt, the fusion construct 
self-assembles into a nanovesicle of 60 nm (similar to the 
size of many pathogens) in which the antigenic motif is dis-
played at the surface. Such nanovesicles have been proven to 
be biocompatible, multivalent, monodisperse and stable for 
up to a year in solution, and are able to induce the secretion 
of chemotactic cytokines in vivo. This immune response is 
characterized by the early secretion of IL-1 (involved in the 
innate immune phase) followed by the induction of a Th-2 
immune response, as shown by the late onset of IL-5 produc-
tion and the up-regulation of specific IgM and IgG antibody 
responses.  
In a different approach, therapeutic containers composed 
of chitosan and an ELR were constructed using an LbL tech-
nique [86]. The resulting microcapsules displayed interesting 
properties as regards their potential use as drug carriers since 
the release profile of the model protein BSA was found to be 
dependent on the number of layers in the capsule architecture 
and on permeability variations due to the temperature re-
sponse of the ELR, thus demonstrating promising features 
for protein delivery applications (Fig. 4).  
Further Use of ELRs in Drug Delivery 
The use of ELRs for controlled drug delivery is not re-
stricted to hydrogels or capsules that entrap the drug. Thus, 
ELRs can be linked to synthetic drugs or active proteins 
chemically or using genetic engineering techniques, respec-
tively. In such constructs, the ELR works as a tag that exerts 
diverse functions [18]. 
For example, many pharmaceutical compounds exhibit 
short half-lives since their small size allows rapid glomerular 
filtration. One solution to this comprises binding these  
compounds to ELRs in order to increase their size 
 
Fig. (3). Self-assembly of the ELR into spherical nanoparticles displaying a corona of antigens from a M. tuberculosis major mem-
brane protein. Cryo-TEM image shows the morphological property of the assembly [124]. Adapted with permission from reference [115]. 
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Fig. (4). Cumulative release of BSA from (Chi/ELR)1, (Chi/ELR)3 and (Chi/ELR)5 microcapsules: , , and , respectively, in 
PBS (pH 7.4) at (A) 25 °C and (B) 37 °C. Reproduced with permission from reference [86]. 
 
[109, 125-127]. In this respect, a fusion construct comprising 
a single monoclonal antibody domain that recognizes TNF 
(TNF-VhH) and an ELR has been reported [127]. The serum 
half-life of the ELR-TNF-VhH protein was 24-fold longer 
than that of the naked antibody fragment and it displayed a 
comparable biological activity. 
The tactic of increasing the size of the drug by incorpo-
rating an ELR has also proved useful in some anticancer 
strategies. One major drawback of many potential anti-
cancer compounds is that only a small percentage of the dose 
administered reaches the tumor site. In order to improve the 
directionality of therapeutic treatment, several approaches 
that attempt to exploit two peculiarities of tumor tissues, 
namely the enhanced permeability and retention (EPR) effect 
[128] and the poor heat dissipation characteristics displayed 
by tumor tissues, which means that the application of local-
ized hyperthermia leads to an increase in temperature in the 
diseased tissue, are being developed. Thus, as a result of the 
EPR effect, the size increase resulting from attachment of the 
drug to the ELR allows the construct to more readily pene-
trate and preferentially accumulate in tumors rather than in 
normal tissues. Moreover, the presence of the ELR in the 
construct makes it sensitive to applied local hyperthermia, 
thus meaning that the drug selectively accumulates in tumors 
[129]. Since the active molecule is not always protein-based, 
chemical modifications to the ELR in order to create reactive 
sites for drug-conjugation purposes are needed. For example, 
a doxorubicin-based drug has been attached to an ELR in 
order to achieve targeted delivery to solid tumors as a result 
of the inverse temperature transition behavior of the elas-
tomeric polymer [130]. Despite the accumulation of macro-
molecules in tumor tissue due to the EPR effect, an addi-
tional obstacle remains: the plasma membrane. Cellular in-
ternalization has been improved by the use of cell penetrat-
ing peptides (CPPs). CPPs are short peptides that are able to 
pass through the plasma membrane and enter the cytoplasm 
[131]. In light of these considerations, doxorubicin delivery 
has also been explored by designing an ELR-based doxoru-
bicin delivery system incorporating a CPP derived from 
HIV-1 Tat protein [132, 133]. Thus, the doxorubicin delivery 
construct containing the Tat protein, an ELR, a lysosomally 
degradable spacer and a cysteine residue conjugated to a 
thiol-based doxorubicin derivative undergoes a phase transi-
tion at 40ºC and its internalization by cells can be enhanced 
using both the CPP and its hyperthermia-induced phase tran-
sition. Along similar lines, a peptide derivative of bovine 
lactoferrin (L12) has been fused to a Tat-ELR construct us-
ing genetic engineering tools. The final chimeric Tat-ELR-
L12 protein showed a marked ability to thermally target can-
cer cells and to inhibit their proliferation by between 60% 
and 90%, depending on the cell line [134]. Another very 
interesting example of the combined use of ELR and CPPs to 
enhance cell uptake has been describe by Chilkoti’s group 
[135]. Assuming that the penetration ability of oligo-arginine 
CPPs depends on the local arginine density, a construct in 
which the ELR acts as a modulator of the interfacial density 
of such residues was constructed. Thus, below the specific 
Tt, which was tuned to be in the range 39-42 ºC, the ELR 
fused with the oligo-arginine-based CPP (Arg5-ELRBC) ex-
ists as a soluble monomer. Micelle self-assembly to give a 
corona composed of the arginine residues is triggered by 
applying mild clinical hyperthermia. An eightfold difference 
in cellular uptake was found between the Arg5-ELRBC and 
both ELRBC (without the arginines) and Arg5-ELR (where 
the ELR is highly hydrophilic). Therefore, a system which 
displays an “off-on” cellular uptake as a consequence of dif-
ferences in local Arg density between the monomer and the 
micelle has been created [135].  
Despite the numerous examples that have already ap-
peared in the literature, a large number of design possibilities 
for controlled drug delivery still remain. The ultimate aim 
should be the formation of a vehicle that is able to sense a 
chemical abnormality in diseased tissue and release the drug 
in response to it in order to correct the imbalance. The 
achievement of such a system would be the ultimate objec-
tive of drug delivery as it would be able to act in a similar 
manner to the body, which exercises close control over the 
release and distribution of its own endogenous biological 
agents. Elastin-based polymers are an interesting option to 
make progress towards this goal due to their ability to sense 
their environment and respond to changes in it. A more in-
depth understanding of the relationship between the structure 
and function of these polymers will lead to the development 
of systems that are able to sense specific physicochemical 
changes associated with diseased tissue and trigger a re-
sponse. The development of such systems is also assisted by 
their recombinant character, which allows polymer design to 
be adapted to the desired application with extraordinary ac-
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curacy. The examples mentioned above demonstrate a strong 
commitment to attaining this goal. 
NANOTECHNOLOGICAL APPLICATIONS OF ELRS 
Since nanotechnology was first discussed in 1959 by 
Richard Feynman, its study and applications have been con-
tinuously growing in all branches of science. Two major 
nanotechnological fields, namely diagnostic and biosensing 
techniques and nanoparticle-based drug/gene/protein deliv-
ery, are especially important for biomedicine. 
Apart from the properties mentioned previously in this 
review, which make them ideal candidates for biomedical 
applications, elastin-like recombinamers are also highly in-
teresting materials from a nanotechnological point of view 
due to their recombinant nature and ability to self-assemble 
[136]. In this section we will focus on the recent confluence 
of nanotechnology and ELRs in the context of both conjuga-
tion with inorganic materials and self-assembled nanostruc-
tures. 
Hybrid Metal- and Semiconductor-ELR Materials 
Metal nanoparticles such as gold, copper or silver have 
attracted the attention of many researchers in the past few 
years due to their unique optical and electronic properties, 
which depend strongly on their size and shape [137-139].  
Gold nanoparticles are of particular interest for biomedi-
cal applications because of their near-infrared absorption 
properties [140] and high surface area to volume ratio, which 
make them good candidates as drug carriers [141] or pho-
tothermal agents [142]. However, gold nanoparticles are 
unstable and prone to irreversibly aggregate. As such, in 
order to increase their stability and provide environmental 
responsiveness (such as to pH or temperature), gold nanopar-
ticles have been conjugated to ELRs [16, 143-145]. 
Alvarez-Rodriguez et al. [143] have developed a one-pot 
method for synthesizing smart ELR-gold nanoparticle hybrid 
materials using a pH- and temperature-sensitive glutamic 
acid-based ELR (Glu15). This reaction is carried out in one 
step by the aqueous reduction of auric acid in the presence of 
Glu15 and an excess of reducing agent. This excess is em-
ployed in order to avoid the formation of ionic gold species. 
Direct visualization by TEM revealed rounded nanoparticles 
with a diameter of between 2 and 11 nm that present ther-
mosensitive properties at acid pH as a result of cluster ag-
gregation at 40°C and an expansion at 4°C. This structure 
reversibility leads to different light absorbance properties, 
thereby opening up the possibility of modulating light ab-
sorption, which is of great interest in bio-sensing or pho-
tothermal therapies.  
Silver has also been investigated in the biomedical field, 
especially due to its antibacterial properties, although its 
cytotoxicity and genotoxicity hinder its possible usage. Con-
jugation with a highly biocompatible material such as an 
ELR may solve this issue. In this sense, Anh et al. have de-
signed a new ELR that is able to nucleate silver after being 
incubated in silver nitrate, thus conferring antibacterial prop-
erties on the recombinamer [146]. 
Semiconductor nanocrystals, also known as quantum dots 
(QDs), have very interesting properties for biomedical 
applications, such as high quantum yield, narrow 
cations, such as high quantum yield, narrow fluorescence 
emission, broad absorption profile and stability against pho-
tobleaching [147]. However, QDs are nonpolar and therefore 
insoluble in aqueous media, thus making them incompatible 
for most biomedical applications. Furthermore, QDs are usu-
ally made of heavy metal ions, with the high toxicity that this 
implies. In order to overcome these drawbacks, QDs must be 
conjugated with other molecules that provide them with the 
properties they require for biomedical use. In this sense, Lao 
et al. have described an antibody-quantum dot (CdSE-ZnS) 
complex that uses an ELR as scaffold [148]. These authors 
constructed a fusion recombinant protein in which the model 
ELR (VPGVG)78 is flanked by a polyhistidine tag at the N 
terminus (for conjugation with the QDs via Zn
2+
) and a pro-
tein L sequence (an antibody binding protein) at the C termi-
nus. The role of this ELR is to confer the fusion protein with  
thermoresponsive behavior, which is a key parameter for 
complex purification. The resulting fusion ELR protein was 
used as an effective inmunofluorescent agent for antibody  
array analysis. In order to test it, the representative carci-
noembryonic tumor marker antigen was chosen. 
Fahmi et al. subsequently described the manufacture of 
CdSe-ELR nanofibers [149]. These authors designed a sim-
ple route for the manufacture of these nanofibers in aqueous 
solution that takes advantage of the self-assembly properties 
of a glutamic acid-containing elastin-like recombinamer. 
Thus, CdSe nanoparticles were prepared by complexation of 
Cd
II
 to the glutamate, followed by selenization with NaHSe 
in an aqueous medium. During generation of the semicon-
ducting nanoparticles, the ELR/CdSe nanoparticles self-
assemble into nanofibers, at neutral pH, due to electrostatic 
interactions.  
The ELR stabilizes the CdSe nanoparticles and controls 
their nucleation, growth and spatial distribution in a process 
that is strongly dependent on the pH of the medium due to 
the presence of carboxylate groups on the heterogeneously 
charged polypeptide shell. The effect of pH is shown in  
Fig. 5: At acid pH, the shell is completely apolar, thus lead-
ing to the formation of agglomerates, whereas upon increas-
ing the pH, the carboxy groups become ionized, thereby re-
ducing their tendency to agglomerate and resulting in elon-
gated lace-like structures (pH 4.8) and nanofibers (pH 7.2). 
Complete disruption of the fibers occurs at pH 10. 
The cytotoxicity of these nanofibers was tested using 
B14 fibroblast cells. They were found to be nontoxic and 
able to cross the cell membrane barrier, thus making them 
promising materials for future medical nanotechnology ap-
plications, such as the diagnosis and treatment of various 
diseases. 
In 2010, the Nobel Prize in Physics was awarded to Kon-
stantin Novoselov and Andre Geim "for groundbreaking 
experiments regarding the two-dimensional material gra-
phene". Graphene is widely expected to prove to be a revolu-
tionary material in the near future due to its outstanding 
properties, some of which, such as its high surface area, 
near-infrared energy absorption or highly sensitive electrical 
properties, are also suitable for the biomedical field and use 
in biomedical applications such as tumor photothermal ther-
apy, cellular imaging, drug delivery or platforms for stem 
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Fig. (5). AFM height images showing the effect of pH on the morphology of self-assembled ELR-CdSe nanostructures. Reproduced 
with permission from reference [149]. 
 
cell differentiation [150-153]. However, as we have seen 
previously for other materials, graphene, or graphene oxide, 
present two mayor drawbacks, namely their poor solubility 
and toxicity. To overcome this problem, graphene is being 
conjugated to other molecules, such as ELRs, to increase its 
solubility and confer biocompatibility. 
Wang et al. [154] have recently designed and produced 
the first graphene-ELR composite hydrogel using a fifty pen-
tapeptide recombinamer (VPGVG)50 followed by a graphene 
binding sequence (HNWYHWWPH). The hydrogels are 
irradiated with near-IR light to induce a local transition of 
the ELRs and produce bending motions, thus confirming the 
absorption of near-IR radiation and opening up the possibil-
ity of future studies of light-controlled dynamic cell culture 
or drug delivery. 
ELR-Based Nanostructures 
ELRs have been widely used as self-assembling materials 
that lead to the formation of nanoparticles. Recombinant 
DNA techniques have allowed block copolymers to be ob-
tained with absolute control of the amino acid composition, 
thereby opening up the possibility of conferring the polymer 
with different responsiveness, such as pH [155], ionic con-
centration [17] and so on, simultaneously. To this end, ELR-
based amphiphilic diblock and triblock copolymers have 
been synthesized in which the amphiphilicity [123, 156] of 
the component blocks is achieved by substituting the amino 
acid (X) in the guest position of the pentamer VPGXG by 
different hydrophilic (glutamic acid, aspartic acid or lysine) 
or hydrophobic (isoleucine or alanine) amino acids. 
Nanoparticle formation occurs when the elastin-like block 
co-recombinamer (ELbcRs) solution is heated above the 
characteristic Tt of the hydrophobic block, at which point the 
co-recombinamer chains organize themselves by hiding the 
hydrophobic blocks from the aqueous environment, thus 
reaching a minimum free energy situation. 
The first example of such self-assembled nanoparticles 
found in the literature was reported as far back as 2000 by 
Lee et al. [23], who reported a di-block ELbcR construct that 
self-assembled under dilute basic conditions (0.1 M NaOH) 
into a narrow distribution of 90 nm micelles, and upon in-
creasing the concentration into worm-like micelles due to the 
aggregation of individual nanoparticles. Numerous other 
studies have been published since then in an attempt to shed 
light on the self-assembly of such elastin-like micelles [122, 
123, 157]. Other morphologies, such as vesicles, are much 
harder to obtain.  
Dash et al. [158] have published an alternative to this 
self-assembly process that leads to the formation of hollow 
vesicles. These authors coated sulfonated polystyrene beads 
with an ELR, which gave them a negative charge, then cross-
linked the ELRs using microbial transglutaminase 
(mTGase). Finally, the PS beads were dissolved using THF 
to provide hollow structures of different sizes (100, 300, 500 
and 1000 nm). These hollow spheres were loaded with poly-
plexes and naked pDNA and studied as nucleic acid delivery 
depot. More recently, Martín et al. obtained micelles and 
vesicles by the self-assembly of ELbcRs [156]. Three differ-
ent polymers (E50A40, E50A40E50, and E100A40) in 
which the component blocks of the three recombinamers 
were the same but with different lengths and architectures 
were used. The authors claimed that the molecular architec-
ture of the ELbcRs is a key parameter in determining the 
structure of the resulting self-assembled nanoparticles. 
E50A40 was found to adopt a 150 nm micellar structure, 
whereas 200 nm hollow vesicles were obtained using the 
other two recombinamers (Fig. 6). 
Vesicles represent a great advance compared with mi-
celles as, although the latter are perfect candidates for the 
encapsulation of hydrophobic molecules, vesicles allow the 
possibility of both entrapping such hydrophobic molecules 
and also using the inner cavity as a carrier for hydrophilic 
guest molecules such as therapeutic agents.  
Although self-assembly is the most widely used tech-
nique for the fabrication of ELR nanoparticles, other tech-
niques have been also reported. Thus, electrospraying [159] 
has been used to generate nanoparticles with diameters of 
about 300-400 nm by dissolving ELRs in trifluoroethanol 
and doxorubicin in a 25:1 trifluoroethanol/ethanol mixture. 
Two glutamic acid-containing ELRs with different molecular 
weights were studied. Glutamic acids were included in these 
sequences for two reasons: first, to provide a negative charge 
to the recombinamers in order to favor the formation of 
nanoparticles during electrospraying by Coulombic repul-
sion, and second, to confer pH responsiveness on them, thus 
allowing tuning of the Tt and thus delivery of the load de-
pending on the pH. The morphology was strongly affected 
by the molecular weight and concentration of the ELR, with 
a decrease in molecular weight resulting in a change from 
fibers and particles with a tail to spherical particles, which 
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Fig. (6). TEM images of self-assembled nanoparticles without staining (top), stained (middle) with 1% uranyl acetate, and freeze-
fractured (bottom): (a,d,g) E50A40, (b,e,h) E100A40, and (c,f,i) E50A40E50. E: Glutamic acid based block; A: Alanine based block. Re-
produced with permission from reference [156]. 
 
were preferentially obtained using ELRs of a low molecular 
weight.  
The ability of ELRs to self-assemble in response to 
changes in their environment makes them highly attractive 
materials for the fabrication of multiple nanostructures with 
different and varying morphologies. This self-assembly be-
havior, together with the ability to conjugate them to differ-
ent inorganic materials, increases their importance and pos-
sible applications from a nanotechnological point of view. 
CONCLUSIONS 
Protein-based biomaterials have become increasingly 
common in the last few years due to the development of new 
molecular biology and genetic engineering techniques that 
allow their recombinant production in an extremely con-
trolled and versatile manner. The excellent properties of 
natural elastin have propelled the development of recombi-
nant versions of this protein-based polymer and have led to 
the so-called elastin-like recombinamers (ELR). This chapter 
has reviewed all the most important applications of ELRs, 
especially tissue engineering, surface engineering, drug de-
livery and the generation of nano-devices, thereby highlight-
ing their enormous utility and potential in the fields of bio-
medicine and biotechnology. 
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